Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed)
The National Cancer Institute (NCI) is offering grants to support research involving small molecules that can help understand disease biology or act as treatments. The grant focuses on discovering molecules that are significant to the health outcomes of various NIH Institutes. Research stages covered include: 1) developing assays for biological targets and disease mechanisms to identify small …
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications for identification of small molecules that function to elucidate the biology of disease as chemical probes or function as agonists or antagonists of disease target(s) for therapy or immun…
Funding Source
Dates
Documents
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers